AI assistant
SnowWorld N.V. — M&A Activity 2008
Jul 30, 2008
3886_iss_2008-07-30_b9f58f23-e64a-49ca-8efe-6f2729c2fde2.pdf
M&A Activity
Open in viewerOpens in your device viewer
P R E S S R E L E A S E
Lelystad, 30 July 2008
Termination of discussions on the acquisition of Bial-Aristegui
_______________________________________________________________________
Fornix BioSciences N.V. (Fornix) and BIAL- S.G.P.S., S.A. (BIAL) have mutually agreed to terminate their discussion for the potential acquisition of the Allergy Division of BIAL in Spain and Portugal known as "BIAL-Aristegui", as referred to in the press release of Fornix dated 31 March 2008. Parties however have agreed to explore, over the coming months, alternative models of cooperation.
END OF PRESS RELEASE
| Further information: | Fornix BioSciences N.V. C.L. Bergman, CEO Fornix BioSciences N.V. Tel. +31 320 26 7799 |
|---|---|
| Website: www.fornix.nl |
Profile of Fornix BioSciences N.V.
Fornix BioSciences N.V. is a listed company (Euronext Amsterdam: AFORBI) which focuses on the development and sale of diagnostic and therapeutic allergen products and the distribution of medical aids and medical and nursing consumables. Fornix BioSciences N.V. has facilities in Lelystad and Beuningen in the Netherlands and Hamburg in Germany. The company currently employs 130 people and is mainly active in the Netherlands and Germany.
The activities are carried on by two divisions, which in turn are made up of operating companies.
The Allergy Division, the most profitable division, consists of Artu Biologicals Europe and, since 1 June 2007, Artu Biologicals Deutschland. It specialises in the development, production and sale of a broad range of patient-friendly immunotherapeutic products under several brand names, including Oralgen® and Igevac®, used to treat allergies caused by agents such as grass and tree pollen and house-dust mites. The development of these products is supported by high-quality R&D and pan-European clinical studies of effectivity.
The Medical Aids Division, consisting of Laprolan in Beuningen, specialises in the marketing, sale and distribution of an extensive range of medical aids and medical and nursing consumables.